Radius Health (RDUS) Misses Q4 EPS by 15c

Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($1.59), $0.15 worse than the analyst estimate of ($1.44). Product revenue for the quarter came in at $7.66 million versus the consensus estimate of $7.03 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• ADNOC Distribution agrees to buy Shell's South Africa unit for $1B
• BMO Capital Reiterates Outperform Rating on HF Sinclair (DINO)